Clenbuterol retards loss of motor function in motor neuron degeneration mice

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Motor neuron degeneration (mnd) mice accumulate lipofuscin-like material in lysosomes.
• This accumulation correlates with progressive motor dysfunction and loss of muscle strength.
• Abnormal spinal motor neurons with eccentric nuclei indicate axonal/synaptic dysfunction.

Purpose of the Study:

• To investigate the therapeutic potential of clenbuterol in mnd mice.
• To assess the impact of clenbuterol on motor deficits and neuronal health.
• To explore clenbuterol's effect on lipofuscin accumulation and synaptic function.

Main Methods:

• Treatment of mnd mice with clenbuterol, a beta(2)-adrenoceptor agonist.
• Assessment of motor dysfunction scores and grip strength.
• Histological analysis of spinal motor neurons to evaluate nuclear eccentricity.

Main Results:

• Clenbuterol treatment opposed the development of motor deficits in mnd mice.
• A reduced proportion of motor neurons with eccentric nuclei was observed in treated mice.
• Clenbuterol also counteracted decreases in grip strength and muscle mass.

Conclusions:

• Clenbuterol treatment improves motor function and synaptic health in mnd mice.
• Beta(2)-agonist therapy shows promise as a therapeutic strategy for lipofuscinoses.
• Targeting axonal regeneration may be beneficial for motor neuron diseases with lipofuscin accumulation.